Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 105,952,381 | reported | 18 Mar 2019 | tx 4+31,022,381 |
| Myovant Sciences Ltd. | 40,765,599 | reported | 04 Jun 2019 | tx 2+3,534,257 |
| Urovant Sciences Ltd. | 22,860,013 | reported | 19 Jun 2019 | tx 27+2,834,915 |
| Arbutus Biopharma Corp | 1,164,000 | reported | 12 Jan 2018 | tx 2+1,164,000 |
| CHIMERIX INC | 60,000 | reported | 09 Jun 2023 | tx 7+243,000 |
| ALUMIS INC. | 49,800 | reported | 30 Jul 2025 | tx 10+263,248−38,000 |
| ROCKET PHARMACEUTICALS, INC. | 45,000 | reported | 20 Jun 2017 | tx 2+69,000 |
| Arcus Biosciences, Inc. | 38,300 | reported | 10 Jun 2025 | tx 13+215,300 |
| SCYNEXIS INC | 22,500 | reported | 02 Jan 2019 | tx 4+96,988 |
| Xenon Pharmaceuticals Inc. | 2,645 | reported | 05 Jun 2025 | tx 7+101,674 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | TENDER | Avalanche Biotechnologies, Inc. | 8,818 | — | |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 13,590 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 13,820 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 5,250 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 5,250 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 5,250 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 3,000 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 1,500 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,500 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 3,500 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 6,476 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 3,360 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 1,000 | — | deriv |
| 30 Jul 2025 | GRANT_AWARD | ALUMIS INC. | 49,800 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 3,140 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 10,450 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Arcus Biosciences, Inc. | 13,300 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Arcus Biosciences, Inc. | 38,300 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 17,012 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 2,645 | 0.00 USD | deriv |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 14,675 | — | |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 23,243 | — | deriv |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 40,567 | — | deriv |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 86,206 | — | deriv |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 28,675 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 15 Jan 2021.